Bioventus Inc. Share
Bioventus Inc. Shareholder Alert: Kaplan Fox Investigates Potential Securities Fraud (BVS)
November 23, 2022 17:06 ET | Kaplan Fox & Kilsheimer LLP
NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Bioventus Inc. (“Bioventus”) (NASDAQ: BVS). If you...
Axsome Logo.png
Axsome Therapeutics to Present at the Guggenheim 4th Annual Immunology and Neurology Conference
November 09, 2022 07:00 ET | Axsome Therapeutics, Inc.
NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
Axsome Logo.png
Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
November 07, 2022 07:00 ET | Axsome Therapeutics, Inc.
Sunosi® third quarter U.S. net sales of $16.8 million Auvelity™ launched and available in U.S. pharmacies SHARP study results announced demonstrating statistically significant improvement in...
ACTIVE HEALTH FOODS, INC. ANNOUNCES ADDITIONAL INDUSTRY LEADERS TO ITS BOARD OF DIRECTORS
June 27, 2022 10:00 ET | Active Health Foods, Inc.
Los Angeles, CA, June 27, 2022 (GLOBE NEWSWIRE) -- ACTIVE HEALTH FOODS, INC. (OTC: AHFD) announces that Dr. Jonathan Wright, of Tahoma, Washington, and his wife, Holly Han, together with Michael...
Color Logo.png
Bio Solvents Market is expected to grow from USD 9.1 Billion in 2020 to USD 15.9 Billion by 2028, at a CAGR of 7.2% during the forecast period 2021-2028 : Greyviews
April 29, 2022 05:50 ET | GreyViews
Pune India, April 29, 2022 (GLOBE NEWSWIRE) -- Bio solvents market is anticipated to grow at a steady growth rate over the forecast period, owing to increasing awareness regarding environmentally...
Vaxil Bio - Logo.jpg
Vaxil Provides Update on Research Activities
March 07, 2022 07:50 ET | Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, March 07, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
VIPC Funding will further Charlottesville's BioHub goals to advance entrepreneurship in the area's biotechnology sector and support tech and other innovation-led sectors with resourcing and connection
VIPC Regional Innovation Fund Grant Awarded to Charlottesville BioHub to Strengthen the Entrepreneurial Ecosystem in the Charlottesville Region
February 24, 2022 12:29 ET | Virginia Innovation Partnership Corporation (VIPC)
Richmond, Virginia, Feb. 24, 2022 (GLOBE NEWSWIRE) -- CvilleBioHub, an industry-led 501c3 nonprofit organization dedicated to strengthening Charlottesville’s biotechnology industry sector, today...
Vaxil Bio - Logo.jpg
Vaxil’s Annual and Special Shareholders Meeting
February 08, 2022 17:30 ET | Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Feb. 08, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Bio - Logo.jpg
Vaxil Provides Final Results on Its Previously Disclosed Research With Ben-Gurion University of the Negev
January 04, 2022 10:02 ET | Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Jan. 04, 2022 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Bio - Logo.jpg
Vaxil Announces Resignation of Director
December 13, 2021 16:30 ET | Vaxil Bio Ltd.
NESS-ZIONA, Israel, Dec. 13, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative biotech company announces that Mr. David Goren has resigned from the...